<div id="readability-page-1"><p>In a report released yesterday, Yang Huang from J.P. Morgan maintained a Buy rating on WuXi AppTec Co., Ltd. Class H, with a price target of <span id="expert-recommendation-target">HK$150.00</span>.</p><h3>Claim 30% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <p>According to TipRanks, Huang is ranked #528 out of 12068 analysts.</p> <p>WuXi AppTec Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of HK$146.84.</p></div>

513120

159570

513700

159316

02359

520690

159506

603259

520880

520500

<p>J.P. Morgan analyst Yang Huang has maintained a Buy rating on WuXi AppTec Co., Ltd. Class H (2359), setting a price target of HK$150.00. The analyst is ranked #528 out of 12,068 analysts according to TipRanks. The consensus among analysts for WuXi AppTec Co., Ltd. Class H is a Strong Buy, with a price target consensus of HK$146.84.</p>

Tip Ranks

GF CSI HK Innovative Drugs Industry ETF(QDII)

China Universal CNI HK Connect Innovative Drugs Industry ETF

Penghua CSI HK Connect Health Care Composite ETF

E Fund Hang Seng SCHK Innovative Drug ETF

WUXI APPTEC

Bosera Hang Seng SCHK Innovative Drug Select ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

WuXi AppTec

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

J.P. Morgan Remains a Buy on WuXi AppTec Co., Ltd. Class H (2359)